Trial Profile
A Phase I/II Study of ATN-161 and Carboplatin in Adult Patients With Recurrent Intracranial Malignant Glioma.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 May 2012
Price :
$35
*
At a glance
- Drugs ATN 161 (Primary) ; Carboplatin (Primary)
- Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma; Gliosarcoma; Oligodendroglioma
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 14 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 14 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 30 Jan 2008 Status changed from in progress to completed.